NYSEMKT: STXS
Stereotaxis Inc Stock Ownership - Who owns Stereotaxis?

Insider buying vs selling

Have Stereotaxis Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul J. IsaacDirector2025-11-1710,000$2.18
$21.80kBuy
Paul J. IsaacDirector2025-11-1420,000$2.24
$44.80kBuy
Paul J. IsaacDirector2025-03-1038,000$1.81
$68.78kBuy
Paul J. IsaacDirector2025-03-071,489$1.79
$2.67kBuy
Paul J. IsaacDirector2025-03-0623,299$1.81
$42.17kBuy

1 of 1

STXS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STXS insiders and whales buy or sell their stock.

STXS Shareholders

What type of owners hold Stereotaxis Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nathan Fischel60.78%56,725,802$127.63MInsider
Dafna Capital Management LLC14.66%13,680,554$30.78MInstitution
Dafna Capital Management LLC14.66%13,680,554$30.78MInsider
Joe E. Kiani13.47%12,567,692$28.28MInsider
Paul J. Isaac8.04%7,499,241$16.87MInsider
Lagoda Investment Management LP5.04%4,707,400$10.59MInstitution
Blackrock Inc4.26%3,976,252$8.95MInstitution
Fred A. Middleton3.91%3,651,486$8.22MInsider
Vanguard Group Inc3.69%3,441,091$7.74MInstitution
Arbiter Partners Capital Management LLC3.06%2,853,856$6.42MInstitution

1 of 3

STXS vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STXS27.82%72.18%Net BuyingNet Buying
INFU25.27%74.73%Net SellingNet Selling
SMTI0.88%99.12%Net Selling
AVR57.55%0.19%Net Buying
OSUR87.71%10.34%Net SellingNet Buying

Stereotaxis Stock Ownership FAQ

Who owns Stereotaxis?

Stereotaxis (NYSEMKT: STXS) is owned by 44.81% institutional shareholders, 116.25% Stereotaxis insiders, and 0.00% retail investors. Nathan Fischel is the largest individual Stereotaxis shareholder, owning 56.73M shares representing 60.78% of the company. Nathan Fischel's Stereotaxis shares are currently valued at $132.17M.

If you're new to stock investing, here's how to buy Stereotaxis stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.